Products & Tools
OncoJourney is the industry’s first syndicated, multi-stakeholder approach to the patient journey buying process. By illuminating the patient flow, it enables you to gauge the influence of different stakeholders, understand the moments of stakeholder variance, identify the points of market leakage, and more….
The Oncology Molecular Diagnostics Monitor aims to provide a complete understanding of the trends, drivers and barriers within the molecular diagnostics landscape, and how they impact diagnosis, management and treatment.
The opportunity for Pharmaceuticals and Biotech companies is enormous. Ipsos Healthcare’s novel new approach to address patient mal-adherence is designed to help realize that opportunity.
Thought leaders and influencers are not simply commentators on change, they are agents of change – with the power to affect the fortunes of pharmaceutical companies.
Cutting edge insights for marketers of medical devices and technology products.
Ipsos has the qualifications and capabilities to support manufacturers payer and market access needs to ensure commercial success in a complex and integrated market.
Making informed investment decisions is a critical part of pharmaceutical product development and marketing strategies. Get Clarity.
Ipsos Healthcare delivers market-leading syndicated patient chart audits across a wide range of disease areas.
EXPECT provides early guidance for product development through an innovative, hybrid qualitative/quantitative interview with Key Opinion Leaders.
Monitoring brand health requires more than just tracking. It requires vision.
A comprehensive research approach developed in response to new multi-customer markets to help pharmaceutical organizations understand the key dynamics driving the market, as well as future opportunities for growth